A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)
Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.
Campus Bio-Medico, Rome, Italy
Yonsei University, College of Medicine, Yonsei Health System, Yonsei Cancer Center, Seoul, Korea, Republic of
Ain Shams University, Cairo, Egypt
Pediatric Emergency Center, Al Saad, Doha, Qatar
El Galaa Teaching Hospital, Cairo, Egypt
Shatby Maternity Hospital, Alexandria, Egypt
HSK, Wiesbaden, Germany
Kocaeli University Hospital, Kocaeli, Turkey
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.